A Study to Evaluate a New Silicone Hydrogel Contact Lens

Sponsor
Bausch & Lomb Incorporated (Industry)
Overall Status
Completed
CT.gov ID
NCT01309893
Collaborator
(none)
66
1
2
2
32.4

Study Details

Study Description

Brief Summary

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses.

Condition or Disease Intervention/Treatment Phase
  • Device: Investigational Lens
  • Device: Air Optix Aqua lens
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Official Title:
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
Jan 1, 2011
Actual Study Completion Date :
Feb 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Investigational Lens

Bausch & Lomb investigational silicone hydrogel contact lens for 1 week; then issued Air Optix Aqua Lens for 1 week.

Device: Investigational Lens
Lenses worn on a daily wear basis for one week

Device: Air Optix Aqua lens
Lenses worn on a daily wear basis for one week

Active Comparator: Air Optix Aqua Lens

Ciba Vision Air Optix Aqua contact lens for 1 week; then issued Investigational Lens for 1 week.

Device: Investigational Lens
Lenses worn on a daily wear basis for one week

Device: Air Optix Aqua lens
Lenses worn on a daily wear basis for one week

Outcome Measures

Primary Outcome Measures

  1. Distance High Contrast logMAR Visual Acuity at 1 Week [Baseline & 1 week]

    Mean difference in distance high contrast logMAR over all lens VAs (visual acuity) from Baseline and 1 Week

Secondary Outcome Measures

  1. Slit Lamp Findings ≥ Grade 2 [1 week]

    Slit lamp findings are measured on a scale of 0-4, where 0=none, and 4=severe. The slit lamp exam is a routine procedure done to evaluate eye health and determine eligibility for clinical trial. It provides view of the different parts of the eye. During the exam, a doctor can look at the front parts of the eye, including the cornea, the lens, the iris and other parts of the anterior segment of the eye. Fluorescein dye may be used during a slit lamp examination to make it easier to detect inflammation, infections, or injured area on the cornea.

  2. Overall Comfort [1 week]

    Comfort measured by participant on a scale of 0-100 with 100 being the most favorable.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.

  • Be myopic and require lens correction from -0.50 D to -5.50 D in each eye.

Exclusion Criteria:
  • Any systemic disease affecting ocular health.

  • Using any systemic or topical medications that will affect ocular physiology or lens performance.

  • An active ocular disease, any corneal infiltrative response or are using any ocular medications.

  • Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.

  • Allergic to any component in the study care products.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bausch & Lomb Rochester New York United States 14609

Sponsors and Collaborators

  • Bausch & Lomb Incorporated

Investigators

  • Study Director: Robert Steffen, OD, MS, Bausch & Lomb Incorporated

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT01309893
Other Study ID Numbers:
  • 687E
First Posted:
Mar 7, 2011
Last Update Posted:
Nov 24, 2014
Last Verified:
Nov 1, 2014
Keywords provided by Bausch & Lomb Incorporated
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details Participants recruited for this 2-week study conducted at three investigational sites in the USA. The first participant was enrolled on 12/17/2010; the last participant exited the study on 01/20/2011.
Pre-assignment Detail 66 participants enrolled; 64 participants completed. Half wore Investigational Lens for 1 week then crossed over to Air Optix Aqua lens for 1 week. The other half wore Air Optix Aqua Lens for 1 week then crossed over to Investigational Lens for 1 week. The order of lens use was randomized and participant-masked.
Arm/Group Title Investigational Lens First, Then Air Optix Aqua Lens Air Optix Aqua Lens First, Then Investigational Lens
Arm/Group Description Enrolled participants spent 1 week using Investigational Lens, and then crossed over to 1 week using Air Optix Aqua lens. The order of contact lens use was randomized and participant-masked. Enrolled participants spent 1 week using Air Optix Aqua Lens, and then crossed over to 1 week using Investigational Lens. The order of contact lens use was randomized and participant-masked.
Period Title: Week 1 - First Intervention
STARTED 33 33
COMPLETED 33 33
NOT COMPLETED 0 0
Period Title: Week 1 - First Intervention
STARTED 33 33
COMPLETED 32 32
NOT COMPLETED 1 1

Baseline Characteristics

Arm/Group Title Entire Study Population
Arm/Group Description All eligible enrolled participants
Overall Participants 66
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
29.6
(9.4)
Sex: Female, Male (Count of Participants)
Female
52
78.8%
Male
14
21.2%
Region of Enrollment (participants) [Number]
United States
66
100%

Outcome Measures

1. Primary Outcome
Title Distance High Contrast logMAR Visual Acuity at 1 Week
Description Mean difference in distance high contrast logMAR over all lens VAs (visual acuity) from Baseline and 1 Week
Time Frame Baseline & 1 week

Outcome Measure Data

Analysis Population Description
All eligible, dispensed eyes
Arm/Group Title Investigational Lens Air Optix Aqua Lens
Arm/Group Description Bausch & Lomb investigational silicone hydrogel contact lens Investigational Lens: Lenses worn on a daily wear basis for one week Ciba Vision Air Optix Aqua contact lens Air Optix Aqua lens: Lenses worn on a daily wear basis for one week
Measure Participants 66 66
Measure eyes 132 132
Least Squares Mean (Standard Deviation) [logMAR]
-0.031
(0.069)
-0.015
(0.071)
2. Secondary Outcome
Title Slit Lamp Findings ≥ Grade 2
Description Slit lamp findings are measured on a scale of 0-4, where 0=none, and 4=severe. The slit lamp exam is a routine procedure done to evaluate eye health and determine eligibility for clinical trial. It provides view of the different parts of the eye. During the exam, a doctor can look at the front parts of the eye, including the cornea, the lens, the iris and other parts of the anterior segment of the eye. Fluorescein dye may be used during a slit lamp examination to make it easier to detect inflammation, infections, or injured area on the cornea.
Time Frame 1 week

Outcome Measure Data

Analysis Population Description
All dispensed eyes
Arm/Group Title Investigational Lens Air Optix Aqua Lens
Arm/Group Description Bausch & Lomb investigational silicone hydrogel contact lens Investigational Lens: Lenses worn on a daily wear basis for one week Ciba Vision Air Optix Aqua contact lens Air Optix Aqua lens: Lenses worn on a daily wear basis for one week
Measure Participants 65 63
Measure eyes 130 126
Number [eyes]
0
0
3. Secondary Outcome
Title Overall Comfort
Description Comfort measured by participant on a scale of 0-100 with 100 being the most favorable.
Time Frame 1 week

Outcome Measure Data

Analysis Population Description
All eligible dispensed eyes
Arm/Group Title Investigational Lens Air Optix Aqua Lens
Arm/Group Description Bausch & Lomb investigational silicone hydrogel contact lens Investigational Lens: Lenses worn on a daily wear basis for one week Ciba Vision Air Optix Aqua contact lens Air Optix Aqua lens: Lenses worn on a daily wear basis for one week
Measure Participants 63 63
Measure eyes 126 126
Least Squares Mean (Standard Deviation) [units on a scale]
57.3
(27.8)
80.8
(27.2)

Adverse Events

Time Frame 1 week
Adverse Event Reporting Description
Arm/Group Title Investigational Lens Air Optix Aqua Lens
Arm/Group Description Bausch & Lomb investigational silicone hydrogel contact lens Investigational Lens: Lenses worn on a daily wear basis for one week Ciba Vision Air Optix Aqua contact lens Air Optix Aqua lens: Lenses worn on a daily wear basis for one week
All Cause Mortality
Investigational Lens Air Optix Aqua Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Investigational Lens Air Optix Aqua Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/66 (0%) 0/66 (0%)
Other (Not Including Serious) Adverse Events
Investigational Lens Air Optix Aqua Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/66 (0%) 0/66 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

Results Point of Contact

Name/Title Dr. Robert Steffen
Organization Bausch & Lomb
Phone 585 338-6399
Email robert.steffen@bausch.com
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT01309893
Other Study ID Numbers:
  • 687E
First Posted:
Mar 7, 2011
Last Update Posted:
Nov 24, 2014
Last Verified:
Nov 1, 2014